Correlation of Atherosclerotic Dyslipidemia with Long-Term Stroke Recurrence in Patients Undergoing Intravenous Thrombolysis for Acute Ischemic Stroke

References

• Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394–405. doi:10.1016/S1474-4422(18)30500-3
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771. doi:10.1161/CIRCULATIONAHA.116.025250
   PubMed Web of Science ®Google Scholar
• Tu WJ, Zhao Z, Yin P, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open. 2023;6(3):e231455. doi:10.1001/jamanetworkopen.2023.1455
   PubMed Web of Science ®Google Scholar
• Mueller L, Pult F, Meisterernst J, et al. Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy. Eur J Neurol. 2017;24(8):1016–1021. doi:10.1111/ene.13330
   PubMed Web of Science ®Google Scholar
• Cui Y, Wang L, Clinical A. Observation of intravenous thrombolysis in acute ischemic stroke with minor trauma. Neuropsychiatr Dis Treat. 2021;17:1983–1987. doi:10.2147/NDT.S290443
   PubMed Web of Science ®Google Scholar
• Sirimarco G, Deplanque D, Lavallée PC, et al. Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke. 2011;42(8):2131–2137. doi:10.1161/STROKEAHA.110.609727
   PubMed Web of Science ®Google Scholar
• López-Montoya P, Cerqueda-García D, Rodríguez-Flores M, et al. Association of gut microbiota with atherogenic dyslipidemia, and its impact on serum lipid levels after bariatric surgery. Nutrients. 2022;14(17):3545. doi:10.3390/nu14173545
   PubMed Web of Science ®Google Scholar
• Julián MT, Pera G, Soldevila B, et al. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study. Eur J Endocrinol. 2021;184(4):587–596. doi:10.1530/EJE-20-1240
   PubMedGoogle Scholar
• Kutkiene S, Petrulioniene Z, Laucevicius A, et al. Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population. Lipids Health Dis. 2018;17(1):208. doi:10.1186/s12944-018-0851-0
   PubMedGoogle Scholar
• Stahel P, Xiao C, Hegele RA, Lewis GF. The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes. Can J Cardiol. 2018;34(5):595–604. doi:10.1016/j.cjca.2017.12.007
   PubMed Web of Science ®Google Scholar
• Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85(1):37–45. doi:10.1161/01.cir.85.1.37
   PubMed Web of Science ®Google Scholar
• Arca M, Montali A, Valiante S, et al. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol. 2007;100(10):1511–1516. doi:10.1016/j.amjcard.2007.06.049
   PubMed Web of Science ®Google Scholar
• Hoshino T, Ishizuka K, Toi S, et al. Atherogenic dyslipidemia and residual vascular risk after stroke or transient ischemic attack. Stroke. 2022;53(1):79–86. doi:10.1161/STROKEAHA.121.034593
   PubMed Web of Science ®Google Scholar
• Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.str.24.1.35
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143–3421. doi:10.1161/circ.106.25.3143
   PubMed Web of Science ®Google Scholar
• Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Expert Opin Pharmacother. 2005;6(5):755–764. doi:10.1517/14656566.6.5.755
   PubMed Web of Science ®Google Scholar
• Sirimarco G, Labreuche J, Bruckert E, et al. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014;45(5):1429–1436. doi:10.1161/STROKEAHA.113.004229
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang R, Song B, et al. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke. Int J Stroke. 2015;10(5):752–758. doi:10.1111/ijs.12471
   PubMed Web of Science ®Google Scholar
• Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128(12):1298–1309. doi:10.1161/CIRCULATIONAHA.113.003008
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Eckel RH, McPherson R. Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol. 2011;31(8):1716–1725. doi:10.1161/ATVBAHA.111.226100
   PubMed Web of Science ®Google Scholar
• Turan TN, Makki AA, Tsappidi S, et al. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010;41(8):1636–1640. doi:10.1161/STROKEAHA.110.584672
   PubMed Web of Science ®Google Scholar
• Kumral E, Evyapan D, Gökçay F, Karaman B, Orman M. Association of baseline dyslipidemia with stroke recurrence within five-years after ischemic stroke. Int J Stroke. 2014;9(Suppl A100):119–126. doi:10.1111/ijs.12341
   PubMedGoogle Scholar
• Hu Y, Ji C. Efficacy and safety of thrombolysis for acute ischemic stroke with atrial fibrillation: a meta-analysis. BMC Neurol. 2021;21(1):66. doi:10.1186/s12883-021-02095-x
   PubMed Web of Science ®Google Scholar
• Findler M, Molad J, Bornstein NM, Auriel E. Worse outcome in patients with acute stroke and atrial fibrillation following thrombolysis. Isr Med Assoc J. 2017;19(5):293–295.
   PubMed Web of Science ®Google Scholar
• Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis. J Clin Neurosci. 2019;60:24–30. doi:10.1016/j.jocn.2018.10.026
   PubMed Web of Science ®Google Scholar
• Horenstein RB, Smith DE, Mosca L. Cholesterol predicts stroke mortality in the women’s pooling project. Stroke. 2002;33(7):1863–1868. doi:10.1161/01.str.0000020093.67593.0b
   PubMed Web of Science ®Google Scholar
• Iso H, Jacobs DR Jr., Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320(14):904–910. doi:10.1056/NEJM198904063201405
   PubMed Web of Science ®Google Scholar
• Sacco RL, Benson RT, Kargman DE, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA. 2001;285(21):2729–2735. doi:10.1001/jama.285.21.2729
   PubMed Web of Science ®Google Scholar
• Chen XW, Nazri Shafei M, Abdul Aziz Z, Nazifah Sidek N, Imran Musa K. Modelling the prognostic effect of glucose and lipid profiles on stroke recurrence in Malaysia: an event-history analysis. PeerJ. 2020;8:e8378. doi:10.7717/peerj.8378
   PubMed Web of Science ®Google Scholar
• Barkas F, Elisaf M, Liberopoulos E, Liontos A, Rizos EC. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome. Atherosclerosis. 2016;247:58–63. doi:10.1016/j.atherosclerosis.2016.02.001
   PubMed Web of Science ®Google Scholar